Results 231 to 240 of about 204,625 (386)

Anti‐KIT Barzolvolimab for Chronic Spontaneous Urticaria

open access: yesAllergy, EarlyView.
We compared the efficacy and safety of four doses of barzolvolimab compared to placebo in reducing symptoms of chronic spontaneous urticaria in a randomized, controlled trial. Across barzolvolimab doses, rapid symptom reduction within 1 week was observed and sustained during 12 weeks.
Marcus Maurer   +11 more
wiley   +1 more source

Sexual dysfunctions in inflammatory bowel disease: role of Mediterranean diet and quality of life

open access: yesAndrology, EarlyView.
Abstract Background Dietary factors and chronic gastrointestinal diseases are frequent determinants of sexual dysfunctions (SD). Whether inflammatory bowel diseases (IBD) are associated with SD is not well known as well as the role of diet and quality of life (QoL).
Lorenzo Romano   +23 more
wiley   +1 more source

Revealing neurovascular coupling at a high spatial and temporal resolution in the living human retina. [PDF]

open access: yesSci Adv
Senée P   +8 more
europepmc   +1 more source

Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: A position statement of the European Expert Panel for Testosterone Research

open access: yesAndrology, EarlyView.
Abstract Introduction Testosterone therapy has become a cornerstone treatment for men with hypogonadism, offering significant benefits such as improved sexual function, mood, muscle mass, and bone density. However, concerns about its cardiovascular safety have historically tempered its use.
Michael Zitzmann   +15 more
wiley   +1 more source

Modulatory Role of Nitric Oxide on the Vasomotor Actions of NPY in Porcine Cerebral Arteries. [PDF]

open access: yesMicrocirculation
Delgado G   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy